CFO Verma Anubhav converted options into 299,850 shares and covered exercise/tax liability with 79,976 shares, increasing direct ownership by 82% to 486,898 units (SEC Form 4)
$MVIS
Industrial Machinery/Components
Technology
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
| Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 06/04/2025 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock(1) | 06/04/2025 | M | 150,000 | A | $0.00 | 417,024 | D | |||
| Common Stock(1) | 06/04/2025 | M | 149,850 | A | $0.00 | 566,874 | D | |||
| Common Stock(2) | 06/05/2025 | F | 79,976 | D | $1.123(3) | 486,898 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Restricted Stock Units | $0.00(4) | 06/04/2025 | A | 150,000 | 06/04/2025(5) | 06/04/2025 | Common stock | 150,000 | $0.00 | 150,000 | D | ||||
| Restricted Stock Units | $0.00(6) | 06/04/2025 | M | 150,000 | 06/04/2025(5) | 06/04/2025 | Common stock | 150,000 | $0.00 | 0 | D | ||||
| Restricted Stock Units | $0.00(6) | 06/04/2025 | M | 149,850 | 06/04/2025(7) | 06/04/2025 | Common stock | 149,850 | $0.00 | 0 | D | ||||
| Restricted Stock Units | $0.00(4) | 06/06/2025 | A | 450,000 | 06/06/2026(8) | 06/06/2028 | Common stock | 450,000 | $0.00 | 0 | D | ||||
| Explanation of Responses: |
| 1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis. |
| 2. Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement. |
| 3. Represents execution price. |
| 4. Each RSU represents a contingent right to receive one share of MicroVision common stock. |
| 5. RSUs vested on June 4, 2025, on the one-year anniversary of grant, upon determination by the Issuer's Compensation Committee of the level of achievement of performance objectives pursuant to the 2025 Executive Bonus Plan. |
| 6. At vesting, converts into shares of common stock on a unit-for-share basis. |
| 7. On June 4, 2024, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 4, 2027, subject to the Reporting Person's continued employment with the Issuer on each vesting date. |
| 8. On June 6, 2025, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 6, 2028, subject to the Reporting Person's continued employment with the Issuer on each vesting date. |
| /s/ Drew G. Markham, as attorney-in-fact | 06/06/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||